Jupiter Neurosciences, Inc. announced on July 10, 2025, that it has regained compliance with the Nasdaq Stock Market’s minimum bid price requirement. The company received confirmation from Nasdaq on July 9, 2025.
The company's common stock maintained an average closing share price of at least $1.00 for a period of thirteen consecutive trading days, from June 18, 2025, to July 8, 2025. This fulfills the requirement under Nasdaq Rule 5550(a)(2).
As a result, Jupiter Neurosciences' shares are no longer considered to be below the minimum bid price requirement, and Nasdaq has closed the matter. This ensures the company's continued listing on the Nasdaq Capital Market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.